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Bovine spongiform encephalopathy (BSE) in cattle and variant Creutzfeldt–Jakob disease in
humans have previously been shown to be caused by the same strain of transmissible spongiform
encephalopathy agent. It is hypothesized that the agent spread to humans following consumption
of food products prepared from infected cattle. Despite evidence supporting zoonotic
transmission, mouse models expressing human prion protein (HuTg) have consistently shown
poor transmission rates when inoculated with cattle BSE. Higher rates of transmission have
however been observed when these mice are exposed to BSE that has been experimentally
transmitted through sheep or goats, indicating that humans may potentially be more susceptible to
BSE from small ruminants. Here we demonstrate that increased transmissibility of small ruminant
BSE to HuTg mice was not due to replication of higher levels of infectivity in sheep brain tissue,
and is instead due to other specific changes in the infectious agent.
Transmissible spongiform encephalopathy (TSE) diseases
(also known as prion diseases) are fatal, infectious neuro-
degenerative diseases of animals, and include bovine
spongiform encephalopathy (BSE) in cattle, scrapie in sheep
and Creutzfeldt–Jakob disease (CJD) in humans. TSEs are
unusual diseases, as the infectious agent is thought to be
composed solely of a misfolded conformer of the normal
host glycoprotein PrPC (Prusiner, 1982). The abnormally
folded conformer (PrPSc) is present in infected tissues of the
central nervous system (CNS) and lymphoreticular system,
and propagates via a templated seeding mechanism, where
the abnormal protein binds to and converts normal PrPC
into the abnormal conformation (Caughey, 2001).
Ruminant TSEs were for many years thought to be of
low risk to humans due to the lack of association between
incidence of natural scrapie in sheep and CJD in humans.
However, in 1996, a new variant of CJD (vCJD) was
identified in humans that presented with a different clinical
and pathological phenotype (Will et al., 1996). In particular,
the affected individuals were of a considerably younger age
than normally expected for CJD. Strain typing studies
performed in mouse panels revealed that the strain of agent
responsible for vCJD was the same as that responsible for
the recent epidemic of BSE in UK cattle (Bruce et al., 1997;
Hill et al., 1997). It was therefore concluded that a zoonotic
transmission of the BSE agent had occurred from cows to
humans via food products prepared from infected cattle. To
date, there have been 177 deaths due to vCJD in the UK
since it was first identified in 1995 (data provided by the
National CJD Surveillance and Research Unit, Western
General Hospital, Edinburgh), and all clinical cases have
occurred in individuals who are homozygous for methio-
nine at codon 129 in the human PrP gene (Zeidler et al.,
1997).
As TSEs present with long preclinical incubation times,
establishing routes and possible frequency of exposure
in humans has been difficult, and all studies have been
performed as retrospective analyses on post-mortem tissue.
In order to model disease transmission in a controllable
laboratory situation, transgenic mouse models that express
the human PrP gene instead of the mouse PrP gene
have been engineered. These models allowed experimental
challenge with cattle BSE (caBSE) in the presence of
human PrP, and it was hoped these models would provide
evidence on routes and risks of exposure of humans to
caBSE. Considerable variation in susceptibility was observed
between different transgenic lines with various constructs
and protein expression levels. However, in general, trans-
mission rates in mice overexpressing human 129M-PrP
were found to be low (0–30%) (Asante et al., 2002; Be´ringue
et al., 2008; Padilla et al., 2011), and caBSE failed to cause
disease in knock-in human PrP transgenic mice (HuMM)
that expressed human PrP at the same levels at WT
mouse PrP (Bishop et al., 2006). Together these experiments
indicated that the transmission barrier between humans
and cattle was high and that the disease was not easily
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transmitted to humans. This may reflect the low number of
clinical cases of vCJD (n5177) compared with the size of the
UK population that may have been exposed to the agent in
the 1980s and 1990s, and the predicted number of possible
silent carriers in the general population, evaluated from
analysis of anonymized lymphoid tissue (de Marco et al.,
2010; Gill et al., 2013; Hilton et al., 2002).
Although sheep and goats were exposed to the same sources
of contaminated feed (but in lower quantities) as cattle
during the BSE epidemic (Ferguson et al., 2002), no natural
cases of BSE have been documented in sheep. Two cases of
natural BSE infection have been identified in goats (Eloit
et al., 2005; Jeffrey et al., 2006; Spiropoulos et al., 2011),
and sheep and goats have been shown to be susceptible
to infection via intracerebral, oral and intravenous experi-
mental exposure (Foster et al., 1993, 1996; Houston et al.,
2000). Hence, BSE infection of small ruminants is possible.
In previous studies, we and others have shown that
experimental sheep BSE (exp-shBSE) and experimental
goat BSE (exp-gtBSE) are more easily transmissible than
caBSE to transgenic mice expressing human PrP (Padilla
et al., 2011; Plinston et al., 2011; Wilson et al., 2013). In two
separate challenges from individual infected animals, we
have shown TSE disease pathology in 40–70% of recipient
knock-in human PrP transgenic mice homozygous for
methionine at codon 129 (HuMM mice), whereas the same
animals showed no signs of disease when inoculated with
caBSE (Bishop et al., 2006; Plinston et al., 2011;Wilson et al.,
2013). In mice overexpressing human 129M-PrP, both
sheep and goat BSE have been shown to transmit with
100% efficiency, compared with 0–30% efficiency with
cattle BSE (Padilla et al., 2011).
These observations are perplexing, as sheep and goat scrapie
do not transmit to HuMM transgenic mice (Plinston et al.,
2011; Wilson et al., 2012, 2013), indicating the increased
susceptibility is not due simply to ovine/caprine PrP
compatibility with human PrP. Another possible explana-
tion is that sheep and goats are able to replicate the BSE
agent to a higher titre in the CNS, and this results in a higher
dose of agent being received by the HuMM transgenic mice.
In order to examine this possibility, we performed titration
bioassay of the caBSE brainstem pool previously used to
challenge HuMM mice (Bishop et al., 2006), and also
brainstem from a case of exp-shBSE. Due to the apparent
absence of a species barrier to cattle and sheep BSE on
transmission to bovine transgenic mice (Espinosa et al.,
2007), titrations were performed in knock-in bovine PrP
transgenic mice (Bov6) (Bishop et al., 2006) to maximize
transmission efficiency and allow direct comparison of
titre. Bov6 Tg mice were maintained on the same genetic
background as the HuMM mice and 129/Ola WT controls,
also allowing direct comparison of the effect of bovine,
human or murine PrP on transmissibility of BSE. Brain
homogenate (10%) was prepared from a caBSE brainstem
pool (BBP 12/92 supplied by the Animal Health and
Veterinary Laboratories Agency) (Bishop et al., 2006;
Plinston et al., 2011), and from exp-shBSE brainstem tissue
(Roslin; AHQ/AHQ J2771 sheep infected orally with BSE
cattle brain; incubation time 559 days). Previous work by us
and by others (Buschmann & Groschup, 2005; Safar et al.,
2002) has shown no difference in titre of BSE pools versus
individual brains. The brainstem pool was thus selected
for titration as this material had previously been used to
challenge Bov6 and HuTg mice (Bishop et al., 2006). Each
inoculum was used to prepare serial dilutions from 1022 to
1027 in sterile saline. Each dilution was inoculated (20 ml,
intracerebrally) into groups of 12 Bov6 transgenic mice. The
1021 homogenate was also inoculated into control 129/Ola
mice and HuMM transgenic mice, to ensure the exp-shBSE
inoculum used was able to cause the same TSE pathology in
HuMM transgenic mice as observed previously. All animals
were monitored daily and scored weekly for signs of clinical
disease and culled either due to intercurrent illness or at a
pre-defined clinical end point. Tissue from each mouse
was analysed post-mortem for presence of TSE-associated
vacuolation (Fraser & Dickinson, 1967) and PrP deposition
using MAb6H4. All experiments were performed under
licence from the UK Home Office and in accordance with
the UK Animals (Scientific Procedures) Act, 1986.
For the purposes of titre determination, we classed all
animals showing both clinical signs of TSE and TSE-
associated pathology as positive transmission. Survivors
were classed as animals that outlived the last positive case in
each dilution group. Animals that were culled early due to
intercurrent illness before the last TSE-positive case in each
group were not included in the analysis. Although clinical
signs of disease in all Bov6 mice were similar, regardless
of the source of BSE inoculum, incubation times for exp-
shBSE in each dilution group were consistently shorter
than the corresponding dilution of caBSE (Table 1).
However infectious titres calculated using the Spearman–
Karber method (Hamilton et al., 1977) were similar for both
inocula; 105.1 ID50 g
21 tissue (median infectious dose) for
caBSE (95% confidence interval, 104.8–105.3) and 105.0 ID50
g21 tissue for exp-shBSE (95% confidence interval, 104.7–
105.4). The difference of less than half a log between titres
was not statistically significant (P50.99985; t-test). Several
survivors were found to show TSE pathology (vacuolation
and/or PrP deposition) when culled due to intercurrent
illness after the last clinical positive animal in each group.
Titre calculations based on TSE pathology alone also
showed no significant difference between caBSE and exp-
shBSE titres (P50.966; t-test). While no signs of disease
were observed in HuMM mice inoculated with caBSE
(Bishop et al., 2006), 7/12 HuMM mice that received
the exp-shBSE inoculum showed TSE related pathology
(PrP deposition and/or vacuolation), confirming previous
reports (Padilla et al., 2011; Plinston et al., 2011).
Infectivity levels in brain tissue from sheep infected with
BSE have been previously analysed by comparative titration
in ARQ/ARQ Romney sheep and RIII mice (Gonza´lez et al.,
2009). Titres reported in RIII mice (105 ID50 g
21) and
Romney sheep (105.4 ID50 g
21) in the study by Gonzalez
et al. (2009) were equivalent to those measured here in
C. Plinston and others
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Bov6 mice (105.0 ID50 g
21). Incubation times for 1021
dilution in RIII mice (389 days) (Gonza´lez et al., 2009) and
129/Ola mice (378 +/225 days; Table 1) were similar,
indicating comparable levels of infectivity and consistent
titres as measured in sheep, WT mice and bovine PrP
transgenic mice. The reasons for the increased transmis-
sibility of BSE to HuMM mice following passage in sheep
and goats are still unclear. Previous studies have shown an
apparent increased virulence of exp-shBSE compared with
caBSE following transmission to transgenic mice over-
expressing bovine or porcine PrP (Espinosa et al., 2009,
2007). More recently, it has been shown that exp-shBSE
can amplify all ovine and bovine PrPC allelic variants by
protein misfolding cyclic amplification (PMCA) more
efficiently than sheep scrapie (Priem et al., 2014).
Importantly, these and other studies have also shown no
change in BSE agent characteristics or PrPSc glycoform
following passage through sheep (Espinosa et al., 2007;
Gonza´lez et al., 2009; Padilla et al., 2011; Plinston et al.,
2011). Levels of proteinase K-resistant PrP (PrP-res)were
found to be lower in exp-shBSE tissue than caBSE tissue
(Padilla et al., 2011; Plinston et al., 2011), yet data here
have established no significant difference in the level of
infectivity present in the exp-shBSE and caBSE infected
brainstem. It is possible that the ovine/caprine PrP
sequence is required to allow a more efficient interaction
of the BSE agent with human 129M-PrP, however it is
important to note that no disease transmission has been
observed in HuMM mice following inoculation with
several isolates of natural and atypical sheep scrapie and
goat scrapie (Wilson et al., 2013, 2012), indicating that it
is not simply the presence of the ovine or caprine PrP
sequence that facilitates transmission to animals expressing
human PrP. In addition, in vitro amplification studies have
shown that human 129M-PrPC is converted to PrP-res with
equal efficiency by BSE PrPSc from both cattle and sheep
brain tissue (Jones et al., 2009), indicating that human
129M-PrP can interact and convert equally well with both
sheep and cattle BSE PrP-res in a cell-free environment.
Together, these data show that the increased transmis-
sibility of exp-shBSE and exp-gtBSE to mice expressing
human 129M PrP is not due solely to PrP sequence,
infectivity level or the convertibility of human 129M-PrP
by ovine/caprine prions. The increased transmissibility of
exp-shBSE in HuTg mice must therefore be due to other
specific changes in the agent and its ability to interact with
the host. These may include differences in cellular factors
such as routing of the inoculum and trafficking of PrP-res,
or the composition and interaction of specific conformers
of abnormal PrP in the inoculum. The identification
of such factors that are critical for zoonosis may aid in
the assessment of future TSE agent outbreaks and the
associated risk to humans from these isolates. As long as
TSE agents remain in the environment, the opportunity for
cross-species transmission to occur remains. Our data have
shown that such cross-species transmission events can have
major effects on the host range and transmissibility of
different TSE agents. In particular we have established that
the emergence or re-emergence of BSE in small ruminants
could have serious public health implications. There is
therefore a strong requirement to continue surveillance
for new emerging TSE strains, or for the appearance of
old strains in new hosts, and quickly assess the risks of
zoonosis.
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